期刊文献+

关于女性冠心病相关危险因素的研究进展 被引量:3

Progress of research on related risk factors of coronary heart disease in women
下载PDF
导出
摘要 传统意义上认为女性因为有雌激素对血管壁的保护作用,故年轻时冠心病的发病率和病死率低于男性,但近几年来国内外研究表明女性冠心病发病率有显著升高的趋势,且趋于年轻化。本文主要从冠心病的传统危险因素、新发的危险因素及其标志物和女性的社会心理因素方面进行探讨,从而提高对女性冠心病的认识,更好地进行预防。 Traditionally,it is believed that morbidity and mortality of coronary heart disease(CHD)in women on young is lower than that of men because of protective effect of estrogen on vascular wall.However,in recent years,domestic and foreign researches indicated that CHD morbidity in women showed a significant increasing trend,and patients tended to younger.The present article explored from traditional and novel risk factors and its markers,and female socio-psychological factors in order to enhance understanding of female CHD and perform better prevention.
作者 王珺男 王永晨 WANG Jun-nan;WANG Yong-chen(Department of General Medicine,Second Affiliated Hospital of Harbin Medical University,Harbin,Heilongjiang,150001,China)
出处 《心血管康复医学杂志》 CAS 2020年第1期127-129,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 冠心病 女性 危险因素 Coronary disease Femininity Risk factors
  • 相关文献

参考文献3

二级参考文献34

  • 1Kelly D, Squire IB, Khan SQ, et al. C -terminal provasopressin (copeptin) is associated with left ventricular dysfunction, remodeling, and clinical heart failure in survivors of myocardial irffaretion [J].J Card Fail, 2008, 14 (9): 739-745.
  • 2Neuhold S, Huelsmann M, Strunk G, et al. Comparison of copeptin, B - type natriuretic peptide, and amino - terminal pro - B - type natriuretic peptide in patients with chronic heart failure : prediction of death at different stages of the disease [J]. J Am Coil Cardiol, 2008, 52 (4) : 266 -272.
  • 3Palazzuoli A, Deckers J, Calabro A, et al. Brain natriuretic peptide and other risk markers for outcome assessment in patients with non - ST - elevation coronary syndromes and preserved systolic function [ J]. Am J Cardiol, 2006, 28 (10): 1322-1328.
  • 4Galvani M, Ferrini D, Ottani F, et al. Natriuretic peptides for risk stratification of patients with acute coronary syndromes [ J ]. Eur J Heart Fail, 2004, 6 (3): 327-333.
  • 5Khan SQ, Dhillon QS, O'Brien RJ, et al. C - Terminal pro - vasopressin (Copeptin) as a novel and prognostic marker in acute myocardial infarction Leicester acute myocardial infarction peptide (LAMP) study [J]. Circulation, 2007, 115 (16): 2103-2110.
  • 6Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease [J]. Am J Cardiol, 1983, 51 (3) : 606.
  • 7Foote RS, Pearlman JD, Siegel AH, et al. Detection of exercise induced ischemia by changes in B -type natriuretic peptides [J].J Am Coll Cardiol, 2004, 44 (10) : 1980 -1987.
  • 8Tousouhs D, Kampoli AM, Stefanadi E, et al. New biochemical markers in acute coronary syndromes [ J]. Curr Med Chem, 2008, 15 (13): 1288 -1296.
  • 9Scirica BM, Cannon CP, Sabatine MS, et al. Concemrations of C - reactive protein and B - type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death [J]. Clin Chem, 2009, 55 (2) : 265 -273.
  • 10Staub D, Morqenthaler NG, Buser C, et al. Use of Copeptin in the detection of myocardial ischemia [ J ]. Clin Chim Acta, 2009, 399 (1/2) : 69 -73.

共引文献68

同被引文献37

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部